A brain-imaging difference can show that an intervention affects a measured signal without establishing that the change is beneficial. That distinction is central to this small Semax experiment. Primary study
Study outline
Twenty-four healthy volunteers were studied: 14 received Semax and 10 placebo. Resting-state fMRI was collected before exposure and at two early follow-up times. The authors reported a larger mapped rostral component of the default-mode network in the Semax group. Primary report
Our appraisal: functional extent is not new brain tissue
The volume or extent of a functional map depends on how the imaging data are processed and thresholded. It should not be described as growth of the brain or creation of new neurons. Those are structural and cellular claims requiring other forms of evidence.
Nor is a larger functional component intrinsically better. A meaningful benefit claim would connect the imaging change to a prespecified cognitive, behavioral, or clinical outcome. Without that connection, a network difference is a physiological observation rather than proof of improved memory.
The short follow-up window also limits persistence claims. An acute effect does not establish repeated-use benefit, lasting network adaptation, or long-term safety. These questions require different schedules and adequately powered studies.
Small imaging studies need particular attention to motion, preprocessing choices, region definitions, and correction for multiple comparisons. These are review questions, not allegations that a specific method was mishandled. Allocation and blinding details should likewise be recovered from the full report rather than assumed from the presence of a placebo group.
The useful conclusion is that an early functional-imaging signal was reported in a small healthy-volunteer sample. That is not the same as demonstrating treatment of a neurological disorder or enhancement of everyday cognition. A responsible evidence page preserves both the human setting and the limited meaning of the endpoint.
Frequently asked questions
Were the participants healthy volunteers?
Yes.
How large was the sample?
Twenty-four participants.
Was a placebo group included?
Yes.
Does a larger functional map mean the brain grew?
No.
Does this establish improved memory?
The imaging finding alone does not.
Were long-term outcomes established?
Not by these acute measurements.
What methodological details need checking?
Allocation, blinding, motion handling, thresholds, and multiplicity control.